- A database of germline p53 mutations in cancer-prone families1998 | Second Faculty of Medicine
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome2003 | Second Faculty of Medicine
- Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours1998 | Second Faculty of Medicine
- p53 mutations in the patients with hepatobiliary affectionsPublication without faculty affiliation
- Prognostic value of p53 mutation analysis in patients with superficialPublication without faculty affiliation
- p53 mutation analysis: approach for pancreatic cancer diagnosticsPublication without faculty affiliation
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome2002 | First Faculty of Medicine
- p53 mutations and PAX5 and SHB genes expression in superficial bladder cancerPublication without faculty affiliation
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlatuion with pathological findings and clinical outcome.2002 | Second Faculty of Medicine
- Expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder cancerPublication without faculty affiliation
- Prognostic significance of p53 mutations and expression of PAX5 and Shb in superficial bladder cancer2001 | Second Faculty of Medicine
- Expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissuePublication without faculty affiliation
- PAX 5 and Shb expression, P53 mutation analysis and P53 expression in superficial bladder cancer2003 | First Faculty of Medicine
- PAX 5 and Shb expression, P53 mutation analysis and P53 expression in superficial bladder cancer2003 | Faculty of Physical Education and Sport
- The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Evaluation of clinical relevance of examining K-ras, P16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer2007 | First Faculty of Medicine
- Expression of the developmental control gene PAX5 in bladder transitional cell carcinoma, its prognostic value and correlation with p53 immunohistochemistry and p53 mutation analysis +1Publication without faculty affiliation
- Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer2007 | Publication without faculty affiliation
- Modelling mutational landscapes of human cancers in vitro2014 | First Faculty of Medicine
- A rare tumor and an ethical dilemma in a family with a germline TP53 mutation2008 | Second Faculty of Medicine
- Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes2015 | First Faculty of Medicine, Third Faculty of Medicine
- Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Chemical and molecular basis of the carcinogenicity of Aristolochia plants2009 | Faculty of Science
- Increased sperm aneuploidy in two male carriers of germline TP53 mutations2011 | Second Faculty of Medicine
- Risk factors in chronic lymphocytic leukemia, validation of flow cytometric detection using RT-PCR and immunohistochemistry2009 | Third Faculty of Medicine
- Practical approach to management of chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Delineating aggressiveness of acute myeloid leukemia in a mouse model carrying mutations of Spi1 (PU.1) and Trp53Publication without faculty affiliation
- The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab2013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Distinct cellular responses to replication stress leading to apoptosis or senescence2019 | Faculty of Medicine in Hradec Králové